| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
4
5
1
5
2
|
|
Zacks Investment Research
2
(Buy)
|
|
Standard & Poor's
5 / 5 Stars
|
|
TheStreet.com
D+
(Sell)
|
Fund Holdings
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 2.76 | 2.76 |
| Stocks | 1.29 | 1.29 |
| Bonds | 0.0 | 0.0 |
| Other | 0.0 | 0.0 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 95.94 | 95.94 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| GlaxoSmithKline PLC | GLAXF | 20.09 | 2.5 |
| Royal Dutch Shell PLC Class B | RDSB | --- | 2.44 |
| Anheuser-Busch Inbev SA | AHBIF | 9.81 | 2.38 |
| Wirecard AG | WDI | --- | 2.35 |
| Sanofi | SAN | --- | 2.11 |
| Restaurant Group (The) PLC | RTN | --- | 1.91 |
| Eni SpA | ENI | --- | 1.84 |
| Fresenius SE & Co KGaA | FRE | --- | 1.81 |
| Gas Natural SDG | GAS | --- | 1.8 |
| Sap AG | SAP | --- | 1.77 |
